Fexofenadine Study On Filipino Children for The Relief of Perennial And Intermittent Allergic Rhinitis
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To determine the safety and efficacy of Fexofenadine (Telfast®) 30mg pediatric tablets on
Filipino children aged 6 to 11 for the relief of symptoms associated with perennial and
intermittent allergic rhinitis.